Oxford Biomedica Plc

Oxford Biomedica (OXB)

Company name:Oxford Biomedica Plc
EPIC:OXBTrading Currency:GBX
Market Sector:SSC5ISIN:GB00BDFBVT43
Market Segment:SSMMShare Type:DE
WWW Address:http://www.oxfordbiomedica.co.uk/Description:ORD 50P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 615.00 images.advfn.com/imagesnew/2/gb/down -8.0 [-1.28] 598.00 625.00 615.00 615.00 615.00 555
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 471.94 76.74 0.39 11.57 - 53.15 - 793.00 - 461.50

Oxford Biomedica Key Figures

(at previous day's close)
Market Cap.471.94m
Shares In Issue76.74m
Prev. Close623.00
PE Ratio53.15 
Dividend Yield-%
EPS - basic11.57p
Dividend PS-p
Dividend Cover- 
Cash Flow PS16.77p
Return On Equity (ROE)21.71%
Operating Margin7.51%
PEG Factor0.01 
EPS Growth Rate4,089.66%
Dividends PS Growth Rate-%
Net Debt45.42m
Gross Gearing69.09%
Quick Assets65.28m
Net Working Capital41.02m
Intangibles / Fixed Assets0.27%
Turnover PS87.02p
Pre-Tax Profit PS6.53p
Retained Profit PS9.83p
Cash PS42.02p
Net Cash PS4.87p
Net Tangible Asset Value PS *45.12p
Net Asset Value PS45.27p
Spread27.00 (4.32%) 

Oxford Biomedica Balance Sheet

OXB:Liabilities+EQOXB:Assets

Share Price Performance

Sample Period HighLow
1 week635.00575.00
4 weeks635.00540.00
12 weeks635.00461.50
1 year793.00461.50

Share Price Chart (5 years)

Oxford Biomedica Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week575.0040.006.96575.000.12613.65
4 weeks561.0054.009.63540.000.09578.87
12 weeks565.0050.008.85461.500.10551.19
26 weeks744.00-129.00-17.34461.500.08604.58
1 year703.90-88.90-12.63461.500.07643.98
3 years199.50415.50208.27185.003.48456.08
5 years261.25353.75135.41150.003.55423.73

Oxford Biomedica Key Management Ratios

Oxford Biomedica Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio25.44 
PE Ratio53.15 
Tobin's Q Ratio 5.31 
Tobin's Q Ratio (excl. intangibles)5.31 
Dividend Yield-%
Market-to-Book Ratio13.58 
Price-to-Pre-Tax Profit PS94.12 
Price-to-Retained Profit PS62.58 
Price-to-Cash Flow PS36.68 
Price-to-Sales PS7.07 
Price-to-Net Tangible Asset Value PS13.63 
Price-to-Cash PS14.64 
Net Working Capital PS53.45 
Price Pct to Working Capital PS11.51%
Earnings Yield1.88%
Average PE61.12 
Years in average1 
PE to PE average86.96%

Oxford Biomedica Financial Ratios

(Leverage Ratios)
Debt Ratio58.59%
Debt-to-Equity Ratio1.41 
Debt-to-Equity Ratio (excl. Intgbl)1.42 
Debt-to-Equity Market Value0.10 
Net Gearing40.40%
Net Gearing (excl. Intangibles)40.45%
Gross Gearing69.09%
Gross Gearing (excl. Intangibles)69.16%
Gearing Under 1 Year25.36%
Gearing Under 1 Year (excl. Intgbl)25.39%
Assets/Equity3.24 
Cash/Equity92.81 
(Liquidity Ratios)
Net Working Capital to Total Assets36.49%
Current Ratio2.44 
Quick Ratio (Acid Test)2.29 
Liquidity Ratio1.13 
Cash & Equiv/Current Assets46.38%
(Solvency Ratios)
Enterprise Value488.85m
CFO/Sales0.19 
CFO/Attributable Profit1.71 
CFO/Assets0.11 
CFO/Debt0.17 
Total Debt/Equity Market Value0.16 
Total Debt/Sales1.16 
Total Debt/Pre-Tax Profit15.49 
Total Debt77.66m
Total Debt/Net Current Assets1.89%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs8 
Beta (60-Mnth)Beta (36-Mnth)
0.39110.3516

Oxford Biomedica Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)5.98%
Return On Assets (ROA)8.48%
Net Profit Margin11.29%
Assets Turnover0.75 
Return On Equity (ROE)21.71%
Return On Investment (ROI)11.83%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio36.89%
Net Income Of Revenues11.29%
(Asset Utilisation Multiples)
Shareholders Equity Turnover3.27 
Fixed Assets Turnover1.87 
Current Assets Turnover1.25 
Net Working Capital Turnover 
Inventory Turnover17.61 
(Other Operating Ratios)
Total Assets-to-Sales1.33 
Debtors-to-Sales39.20%
Debt Collection Period143.07Days

Oxford Biomedica Dividends

Sorry No Data Available

Oxford Biomedica Fundamentals

 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
turnover15.91100.00%27.78100.00%37.59100.00%66.78100.00%m
pre tax profit-16.98-106.74%-20.31-73.11%-11.76-31.29%5.017.51%m
attributable profit-13.02-81.83%-16.64-59.91%-9.02-23.99%7.5411.29%m
retained profit-13.02-81.83%-16.64-59.91%-9.02-23.99%7.5411.29%m
eps - basic (p)-0.51 -0.60 -0.29 11.57 
eps - diluted (p)-0.51 -0.60 -0.29 10.89 
dividends per share- - - - 

Oxford Biomedica Balance Sheet

 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
OXB:Liabilities+EQOXB:AssetsOXB:Liabilities+EQOXB:AssetsOXB:Liabilities+EQOXB:AssetsOXB:Liabilities+EQOXB:Assets
 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
ASSETS
fixed assets fixed assets24.4047.05%27.5148.32%25.3738.79%31.7928.28%m
intangibles intangibles1.743.36%1.332.34%0.100.15%0.120.10%m
fixed investments fixed investments--%0.661.15%2.954.52%10.979.76%m
current assets - other current assets - other--%--%--%--%m
stocks stocks2.715.22%2.203.87%3.335.09%4.253.78%m
debtors debtors13.6526.33%9.9017.39%19.3229.54%33.0329.39%m
cash & securities cash & securities9.3618.04%15.3426.93%14.3321.91%32.2428.69%m
TOTAL51.85100%56.94100%65.40100%112.40100%m
LIABILITIES
creditors - short creditors - short13.1725.40%9.3216.36%21.7633.27%28.5125.36%m
creditors - long creditors - long27.7953.59%35.0161.49%37.4957.33%49.1543.73%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL40.9678.99%44.3377.85%59.2690.60%77.6669.09%m
EQUITY
ord cap, reserves ord cap, reserves10.8921.01%12.6222.15%6.159.40%34.7430.91%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL10.8921.01%12.6222.15%6.159.40%34.7430.91%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Oxford Biomedica Cash Flow Statement

31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
Operating CF-13.12-5.112.9812.87m
Pre-Financing CF-29.80-11.521.052.77m
Retained CF-4.845.98-1.0117.92m

Oxford Biomedica Brokers

NameActivityTypeMnemonicCode
J.P. Morgan Cazenove LimitedMarket Maker(MME)Broker/DealerCAZRCAZEGB2L
Nomura Code Securities LimitedMarket Maker(MME)Broker/DealerCODECODCGB21
Collins Stewart Europe LimitedMarket Maker(MME)Broker/DealerCSCSCSTEGB21
Evolution Securities LimitedMarket Maker(MME)Broker/DealerEVOEVBGGB21MMT
Canaccord Genuity LimitedMarket Maker(MME)Broker/DealerCANAHOARGB21001
Liberum Capital LimitedMarket Maker(MME)Broker/DealerLIBCLCAPGB21
Panmure Gordon (UK) LimitedMarket Maker(MME)Broker/DealerPMURPMURGB2L
Shore Capital Stockbrokers LtdMarket Maker(MME)Broker/DealerSCAPSHOCGB21
Merrill Lynch InternationalMarket Maker(MME)Broker/DealerMLSBSNCSGB2LBIC
Winterflood Securities LtdMarket Maker(MME)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
LSE
OXB
Oxford Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191206 08:19:16